Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-05

FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lupin Pharmaceuticals' valsartan and hydrochlorothiazide combination, making this generic product available. It …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valsartan and Hydrochlorothiazide (Valsartan and Hydrochlorothiazide)

Snippet

SUPPL AP for VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)